StemPar Sciences
Mill Valley · Founded 2009
About StemPar Sciences
StemPar is developing a pipeline of powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their
Company Facts
- Founded: 2009
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Private Equity
- Last round: Private Equity (Jan 2013)
- Website: stempar.com
- Phone: [email protected]
Canonical: https://fsome.com/organization/stempar-sciences-8463830 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.